Efficacy of Fractional Microneedle Radiofrequency and Fractional Erbium-Doped Glass 1,565-nm for Baggy Lower Eyelids

Last updated: January 19, 2020
Sponsor: Xijing Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Skin Aging

Treatment

N/A

Clinical Study ID

NCT04237324
No.KY20172045-C-1
  • Ages 18-60
  • All Genders

Study Summary

The purpose of this study was to compare the efficacy and safety of FMR and NAFL in the treatment of baggy lower eyelids(BLEs)

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients with Bags lower eyelids ( BLEs )；

  2. Two senior attending surgeons diagnosed the BLEs;

  3. The clinical diagnosis standard was mild swelling or puffiness under the eyes;

  4. Between 18 to 60 years old.

Exclusion

Exclusion Criteria:

  1. History of retinoic acid;

  2. History of hormone use;

  3. History of keloids;

  4. History of injection of botulinum toxin or filler at the site of treatment;

  5. Skin inflammation or facial infection;

  6. Pregnancy or lactation.

Study Design

Total Participants: 15
Study Start date:
January 01, 2018
Estimated Completion Date:
December 30, 2021

Study Description

Fifteen baggy lower eyelids(BLEs) volunteers were recruited prospectively. Everyone was divided into two groups with FMR and NAFL according to the random number table. One side of the face was treated with FMR device and the other side was treated with NAFL device. Subjective and objective adverse reactions were recorded during the operation. Subjective adverse reactions were recorded after each treatment. The VAS score of patient satisfaction and the blind method score of standard photo observer were used for subjective evaluation, and the objective evaluation was carried out by using VISIA，Antera-3D and CineScan.

Connect with a study center

  • Department of Plastic Surgery, Xijing Hospital

    Xi'an, Shaanxi 710032
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.